Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently required for the early detection of HCC and the development of novel therapeutic approaches. Glypican‐3 (GPC3), an oncofetal proteo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicinal research reviews 2018-03, Vol.38 (2), p.741-767
Hauptverfasser:	Zhou, Fubo, Shang, Wenting, Yu, Xiaoling, Tian, Jie
Format:	Artikel
Sprache:	eng
Schlagworte:	glypican‐3 hepatocellular carcinoma Liver cancer Medical imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!